This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04177/identifier/pdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB04177/identifier/pubchem-compound/
n9http://linked.opendata.cz/resource/drugbank/drug/DB04177/identifier/pubchem-substance/
n8http://linked.opendata.cz/resource/drugbank/drug/DB04177/identifier/drugbank/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://linked.opendata.cz/resource/drugbank/drug/DB04177/identifier/chemspider/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04177
rdf:type
n3:Drug
n3:description
3 beta,14-Dihydroxy-5 beta-card-20(22)enolide. A cardenolide which is the aglycon of digitoxin. Synonyms: Cerberigenin; Echujetin; Evonogenin; Thevetigenin. [PubChem]
n3:group
experimental
owl:sameAs
n13:DB04177 n14:DB04177
dcterms:title
4-(3,14-Dihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One
adms:identifier
n7:241192 n8:DB04177 n9:46508220 n10:DTX n11:46936912
n3:IUPAC-Name
n4:271B41A6-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B41AC-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B41AB-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B41A8-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B41A9-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B41AA-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B41A4-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B41A5-363D-11E5-9242-09173F13E4C5 n4:271B41A2-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B41A3-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B41B2-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B41B3-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B41AD-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B41AE-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B41B0-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B41AF-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B41B1-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B41B8-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B41BA-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B41BB-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B41B7-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B41B6-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B41B9-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B41A7-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B41B4-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B41B5-363D-11E5-9242-09173F13E4C5